About OBAI
Open Brain AI
Open Brain AI provides tools for the automatic analysis and scoring of language and we focus in addressing learning challenges stemming from neurological, psychiatric, and behavioral conditions. OBAI solutions are designed to support early screening processes, offering significant educational and clinical advantages.
Open Brain AI has been founded and developed by Dr.
Charalambos Themistocleous.
OBAI's development draws upon a rich history. Our foundational grapheme-to-phoneme
application dates back to 2007. Subsequently, we leveraged our machine learning
expertise in significant research, such as in the characterization of speakers with
a
different dialects (see Themistocleous's publications),
the identification of patients with
Mild Cognitive
Impairment
(Themistocleous, Eckerström, Kokkinakis, 2018) and subtyping patients with
Primary
Progressive
Aphasia (e.g., Themistocleous,
Ficek, Webster, den Ouden, Hillis, and Tsapkini,
2021). We've also developed computational tools for scoring spelling and
other
neurocognitive tests (Themistocleous, Neophytou,
Rapp, Tsapkini, 2020).
Amidst the global pandemic of 2020, we secured the Open Brain AI domain name,
unifying our diverse tools under the OBAI interface.